Health score, price, valuation, risk signals, and key metrics at a glance.
SiriusPoint Ltd. provides multi-line reinsurance and insurance products and services worldwide. It operates in four segments: Global P&C Programs, Global Reinsurance, Global Accident & Health, and London Market Specialty. Global P&C Programs segment offers programs space, by further strengthening its offering to clients and distribution partners globally. , Global Reinsurance segment provides casualty, property, and other specialties, such as proportional and excess of loss, treaty and facultative, aviation and space, marine and energy and, credit to insurance and reinsurance companies, government entities, and other risk bearing vehicles. London Market Specialty segment provides London casualty, energy, property, and marine leaders services. It provides accident and health, property and casualty, aviation and space, credit, surety, marine and energy, and mortgage. It offers medical insurance products, trip cancellation programs, medical management services, and 24/7 emergency medical and travel assistance services. The company was formerly known as Third Point Reinsurance Ltd. and changed its name to SiriusPoint Ltd. in February 2021. SiriusPoint Ltd. was incorporated in 2011 and is headquartered in Pembroke, Bermuda.
Grade capped at D — Interest coverage below 1× (-0.6x) — earnings cannot cover interest. Strongest: Growth (22/25); weakest: Balance Sheet & Red Flags (14/25).
Today's multiple positioned against its own trailing range — a visual premium/discount check.
Currently near its 15-quarter median.
Currently above its 20-quarter median.
Data-driven signals worth keeping an eye on across the last 8 quarters
The company posted negative operating margins in recent quarters — core operations are unprofitable.
FCF/Net Income has dropped below 0.7x in 4 quarters — monitor for earnings quality deterioration.
as of June 2026
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
Currently above its 20-quarter median.
FCF turned negative in 3 of the last 8 quarters — occasional cash consumption.
Shares outstanding increased 5.7% — significant dilution, likely from stock compensation or capital raises.